» Portfolio News

03.10.17

NOXXON publishes preclinical Proof-of-Concept Data for Lead Product NOX-A12 in Combination with Checkpoint Inhibitors

Read more...

29.09.17

NOXXON Supervisory Board elects experienced US & EU Biotech Veteran Don deBethizy Chairman

Read more...

28.09.17

NOXXON provides Update on ongoing Phase 1/2 clinical Trial with Lead Program NOX-A12

Read more...

18.07.17

NOXXON issues first Tranche of ODIRNANE Bonds

Read more...

11.07.17

NOXXON Pharma announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the Euronext Growth Market 

Read more...